Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor α monoclonal antibody (Infliximab)
Jung Hoon Lee, Tae Nyeun Kim, Sun Taek Choi, Byung Ik Jang, Kyeong-Cheol Shin, Sam Beom Lee, Young Ran Shim
Korean J Intern Med. 2007;22(1):24-27. Published online 2007 Mar 31 DOI: https://doi.org/10.3904/kjim.2007.22.1.24
Citations to this article as recorded by 
Advances in Management of Intestinal Behçet’s Disease: A Perspective From Gastroenterologists
Jae Hee Cheon
Journal of Rheumatic Diseases.2021; 28(1): 4. CrossRef
An Overview of Conventional and Recent Treatment Options for Behcet’s Disease
Kader Cetin Gedik, Micol Romano, Roberta A. Berard, Erkan Demirkaya
Current Treatment Options in Rheumatology.2020; 6(2): 99. CrossRef
Update on the Treatment of Behcet’s Disease of the Small Bowel with Biologic Agents
Yehyun Park, Jae Hee Cheon
Current Gastroenterology Reports.2020;[Epub] CrossRef
Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet’s disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants
Kenji Watanabe, Satoshi Tanida, Nagamu Inoue, Reiko Kunisaki, Kiyonori Kobayashi, Masakazu Nagahori, Katsuhiro Arai, Motoi Uchino, Kazutaka Koganei, Taku Kobayashi, Mitsuhiro Takeno, Fumiaki Ueno, Takayuki Matsumoto, Nobuhisa Mizuki, Yasuo Suzuki, Tadakaz
Journal of Gastroenterology.2020; 55(7): 679. CrossRef
Updated treatment strategies for intestinal Behçet’s disease
Yong Eun Park, Jae Hee Cheon
The Korean Journal of Internal Medicine.2018; 33(1): 1. CrossRef
Anti-Tumor Necrosis Factor Therapy in Intestinal Beh Ccedil;et rsquo;s Disease
Jihye Park, Jae Hee Cheon
Gut and Liver.2018; 12(6): 623. CrossRef
Update on the Medical Management of Gastrointestinal Behçet’s Disease
Giuseppe Lopalco, Donato Rigante, Vincenzo Venerito, Claudia Fabiani, Rossella Franceschini, Michele Barone, Giovanni Lapadula, Mauro Galeazzi, Bruno Frediani, Florenzo Iannone, Luca Cantarini
Mediators of Inflammation.2017; 2017: 1. CrossRef
Treatment and outcomes: medical and surgical treatment for intestinal Behçet's disease
Tadakazu Hisamatsu, Mari Hayashida
Intestinal Research.2017; 15(3): 318. CrossRef
Intestinal Behçet's Disease: A True Inflammatory Bowel Disease or Merely an Intestinal Complication of Systemic Vasculitis?
Duk Hwan Kim, Jae Hee Cheon
Yonsei Medical Journal.2016; 57(1): 22. CrossRef
Quantitative Histone Mass Spectrometry Identifies Elevated Histone H3 Lysine 27 (Lys27) Trimethylation in Melanoma
Deepanwita Sengupta, Stephanie D. Byrum, Nathan L. Avaritt, Lauren Davis, Bradley Shields, Fade Mahmoud, Matthew Reynolds, Lisa M. Orr, Samuel G. Mackintosh, Sara C. Shalin, Alan J. Tackett
Molecular & Cellular Proteomics.2016; 15(3): 765. CrossRef
Efficacy of anti-TNF alpha in severe and/or refractory Behçet's disease: Multicenter study of 124 patients
H. Vallet, S. Riviere, A. Sanna, A. Deroux, G. Moulis, O. Addimanda, C. Salvarani, M. Lambert, P. Bielefeld, P. Seve, J. Sibilia, Jl Pasquali, Jb Fraison, I. Marie, L. Perard, L. Bouillet, F. Cohen, D. Sene, Y. Schoindre, O. Lidove, P. Le Hoang, E. Hachul
Journal of Autoimmunity.2015; 62: 67. CrossRef
Adalimumab for the Treatment of Japanese Patients With Intestinal Behçet’s Disease
Satoshi Tanida, Nagamu Inoue, Kiyonori Kobayashi, Makoto Naganuma, Fumihito Hirai, Bunei Iizuka, Kenji Watanabe, Keiichi Mitsuyama, Takuya Inoue, Yoshiaki Ishigatsubo, Yasuo Suzuki, Masakazu Nagahori, Satoshi Motoya, Shiro Nakamura, Vipin Arora, Anne M. R
Clinical Gastroenterology and Hepatology.2015; 13(5): 940. CrossRef
Behçet's disease: Review of management
Jagdish R. Nair, Robert J. Moots
Indian Journal of Rheumatology.2015; 10: S84. CrossRef
Diagnosis and management of intestinal Behçet’s disease
Tadakazu Hisamatsu, Makoto Naganuma, Katsuyoshi Matsuoka, Takanori Kanai
Clinical Journal of Gastroenterology.2014; 7(3): 205. CrossRef
Biotherapies in Behçet's disease
Cloé Comarmond, Bertrand Wechsler, Bahram Bodaghi, Patrice Cacoub, David Saadoun
Autoimmunity Reviews.2014; 13(7): 762. CrossRef
The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet’s disease: indication of anti-TNFα monoclonal antibodies
Tadakazu Hisamatsu, Fumiaki Ueno, Takayuki Matsumoto, Kiyonori Kobayashi, Kazutaka Koganei, Reiko Kunisaki, Fumihito Hirai, Masakazu Nagahori, Mitsunobu Matsushita, Kenji Kobayashi, Mitsumasa Kishimoto, Mitsuhiro Takeno, Masanori Tanaka, Nagamu Inoue, Tos
Journal of Gastroenterology.2014; 49(1): 156. CrossRef
Traitement de la maladie de Behçet
C. Comarmond, B. Wechsler, P. Cacoub, D. Saadoun
La Revue de Médecine Interne.2014; 35(2): 126. CrossRef
Update on the therapy of Behçet disease
Zeinab Saleh, Thurayya Arayssi
Therapeutic Advances in Chronic Disease.2014; 5(3): 112. CrossRef
Combination therapy of infliximab and thalidomide for refractory entero-Behcet's disease: a case report
Yue Li, Zelong Han, Xianfei Wang, Zhihui Mo, Wei Zhang, Aimin Li, Side Liu
BMC Gastroenterology.2013;[Epub] CrossRef
A Case of Intestinal Beh^|^ccedil;etʼs Disease with Perforated Ulcer Concurrent with Myelodysplastic Syndrome and Trisomy 8
Yusuke KAWASAKI, Hiroaki TERAJIMA, Shugo UEDA, Akiko FUKUNAGA, Masato YAGITA
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2013; 74(6): 1547. CrossRef
A Case of Intestinal Behçet's Disease Complicated Enterocutanous Fistula with a Good Response to Adalimumab
IL Hwan Oh, Jin Ok Kim, Young Jae Byun, Yoon-Kyoung Sung, Chan-Bum Choi, Tae-Hwan Kim, Jae-Bum Jun, Wan-Sik Uhm
Journal of Rheumatic Diseases.2012; 19(3): 147. CrossRef
A Case of Intestinal Behçet's Disease Treated with Infliximab Monotherapy Who Successfully Maintained Clinical Remission and Complete Mucosal Healing for Six Years
Yuriko Maruyama, Tadakazu Hisamatsu, Katsuyoshi Matsuoka, Makoto Naganuma, Nagamu Inoue, Haruhiko Ogata, Yasushi Iwao, Takanori Kanai, Toshifumi Hibi
Internal Medicine.2012; 51(16): 2125. CrossRef
Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients
Aikaterini Arida, Kalliopi Fragiadaki, Eirini Giavri, Petros P. Sfikakis
Seminars in Arthritis and Rheumatism.2011; 41(1): 61. CrossRef
Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease
Shigeru Iwata, Kazuyoshi Saito, Kunihiro Yamaoka, Shizuyo Tsujimura, Masao Nawata, Kentaro Hanami, Yoshiya Tanaka
Modern Rheumatology.2011; 21(2): 184. CrossRef
Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease
Shigeru Iwata, Kazuyoshi Saito, Kunihiro Yamaoka, Shizuyo Tsujimura, Masao Nawata, Kentaro Hanami, Yoshiya Tanaka
Modern Rheumatology.2011; 21(2): 184. CrossRef
Response Rates to Medical Treatments and Long-term Clinical Outcomes of Nonsurgical Patients With Intestinal Behçet Disease
Moon Jae Chung, Jae Hee Cheon, Seung Up Kim, Jae Jun Park, Tae Il Kim, Nam Kyu Kim, Won Ho Kim
Journal of Clinical Gastroenterology.2010; 44(6): e116. CrossRef
TNF- antagonists beyond approved indications: stories of success and prospects for the future
M. P. Karampetsou, S.- N. C. Liossis, P. P. Sfikakis
QJM.2010; 103(12): 917. CrossRef
Subtotal colectomy for intestinal Behcet’s disease: a histopathological surprise
Abhijit D. Hiregoudar, Mukunda M. Battal, N. Vishwanath, S. C. Nadaf, Ravikala Rao, U. S. Dinesh
Indian Journal of Surgery.2009; 71(3): 159. CrossRef
Intestinal Behçetʼs disease
Aekarach Ariyachaipanich, Charles Berkelhammer, Haidy Nicola
Inflammatory Bowel Diseases.2009; 15(12): 1769. CrossRef
Treatment strategies for Behçet's disease
Izzet Fresko, Hasan Yazici
Expert Opinion on Pharmacotherapy.2008; 9(18): 3211. CrossRef
Patterns of Recurrence and Prognosis in Patients with Intestinal Behçet's Disease Who Underwent a Bowel Resection
Hyuk Hur, Byung Soh Min, Jin Soo Kim, Kang Young Lee, Yoon-Ah Park, Seung Hyuk Baik, Seung Kook Sohn, Chang Hwan Cho, Jae Hak Kim, Won Ho Kim, Nam Kyu Kim
Journal of the Korean Society of Coloproctology.2008; 24(3): 166. CrossRef